Search - tctmd.com

Displaying 601 - 620 of 1215

Sort: Relevancy | Date

News Daily News

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

May 12, 2014

News Daily News

Clinical Stroke Rate After Open AVR Higher than Expected

Leah Lawrence

May 08, 2014

News Daily News

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

May 07, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Industry News

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

May 05, 2014

News Daily News

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

Yael L. Maxwell

May 01, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

April 21, 2014

News Daily News

Radial Access in Primary PCI Offers Sustained Survival Benefit Even After Long Delays

Caitlin E. Cox

April 18, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

April 09, 2014

News Daily News

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Yael L. Maxwell

April 08, 2014

News Daily News

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

News Conference News ACC 2014

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Jason Kahn

March 31, 2014

Advertisement

Many Patients Referred for Renal Denervation Improve with Medication Adjustment

Clinical Stroke Rate After Open AVR Higher than Expected

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

Boston Scientific Reports Key Data at the 35th Annual Scientific Sessions of the Heart Rhythm Society

Bivalirudin Safer Than Heparin Alone in ‘Real-World’ PCI Patients Without STEMI

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

Radial Access in Primary PCI Offers Sustained Survival Benefit Even After Long Delays

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Cardiovascular Devices Make Up Largest Class of FDA Device Recalls Since 2005

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

HEAT PPCI: Results Favoring Heparin over Bivalirudin Raise Scientific, Ethical Issues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content